Vaccine Preclinical Toxicity Study Guidance Under Development
Executive Summary
FDA's Center for Biologics Evaluation & Research is producing a guidance for industry on preclinical toxicity studies for vaccines
You may also be interested in...
Vaccine Preclinical Toxicity Study Workshop Will Address Dosing And Design
A workshop by FDA's Center for Biologics Evaluation & Research on preventative vaccine development Dec. 2-3 will consider the maximum dose for animal toxicology studies
Vaccine Preclinical Toxicity Study Workshop Will Address Dosing And Design
A workshop by FDA's Center for Biologics Evaluation & Research on preventative vaccine development Dec. 2-3 will consider the maximum dose for animal toxicology studies
FDA Pediatrics Office Under Murphy Plans To Recruit Review Div. Liaisons
FDA's Office of Pediatric Drug Development & Special Initiatives hopes to attract an expert from every drug review division to serve as a liaison in assessing pediatric drug applications.